ClearFlow, Inc.

ClearFlow, Inc. manufactures specialized medical devices for cardiac surgery and cardiothoracic care. The company's primary product is PleuraFlow Active Chest Tube Clearance (ACT), a technology designed to prevent Retained Blood Syndrome and reduce postoperative complications in cardiac surgery patients. The PleuraFlow system actively clears blood and fluid from the thoracic cavity after surgery, demonstrating significant clinical benefits including 41% reduction in Retained Blood Syndrome, 17% reduction in postoperative atrial fibrillation, and 30% reduction in ICU length of stay when integrated into Enhanced Recovery After Surgery (ERAS) protocols. The company also offers ClearFix, a rigid sternal fixation system for stabilization and fixation of anterior chest wall fractures, including sternal fixation following sternotomy and sternal reconstructive procedures. ClearFlow's products are deployed in leading cardiac institutions and ICUs. The technology is supported by clinical evidence, including peer-reviewed publications demonstrating improved patient outcomes and resource utilization. The company serves cardiac surgeons, cardiothoracic surgical teams, and hospital ICU departments focused on reducing postoperative complications and improving recovery times in cardiac surgery populations.